Skip to main content
. 2016 Aug;15(4):42–47.

Table 2.

Interpretation of Functional Testing and Supplement Recommendations

Test Result Diagnoses Interventions (including dose) Time Frame for Continuing Supplementation
Painful menstruation4 Omega-3 fatty acid EPA/DHA (1 g QD) Monitor and continue as needed
Low vitamin D,25-OH (31 ng/mL) Vitamin D insufficiency Vitamin D3 (5000 IU QD) Monitor and continue as needed
Elevated serum homocysteine (10.5 μmol/L) and MTHFR C677T Decreased methylation efficiency, B12 deficiency Sublingual vitamin B12 2000 mg (methylcobalamim) Monitor and continue as needed
Low magnesium, RBC (3.3 mg/dL) Magnesium deficiency Magnesium (360 mg daily) Monitor and continue as needed
  • Elevated lactoferrin (8.3 mg/mL) and calprotectin (65 μg/g)

  • Low secretory IgA (<0.1 mg/dL)

Signs of bowel inflammation and low immune function in the bowel mucosa TruFiber prebiotic plus Probiotic (Prescript Assist) Monitor and continue as needed
Low pancreatic elastase (122 μg/mL) Inefficient digestive enzyme function Betaine HCL and digestive enzymes September–October 2015, discontinued

Abbreviations: EPA/DHA, eicosapentaenoic acid/docosahexaenoic acid; QD, 1 per day; HCL, hydrochloric acid.